Joubert, MoniqueReva, Oleg N.Korotetskiy, Ilya S.Shvidko, Sergey V.Shilov, Sergey V.Jumagaziyeva, Ardak B.Kenesheva, Sabina T.Suldina, Natalya A.Ilin, Aleksandr I.2020-08-072020-08-072019-07Joubert M, Reva ON, Korotetskiy IS, Shvidko SV, Shilov SV, Jumagaziyeva AB, Kenesheva ST, Suldina NA, Ilin AI. 2019. Assembly of complete genome sequences of negative-control and experimental strain variants of Staphylococcus aureus ATCC BAA-39 selected under the effect of the drug FS-1, which induces antibiotic resistance reversion. Microbiology Resource Announcements 8:e00579-19. https://doi.org/10.1128/MRA.00579-19.2576-098X (online)10.1128/MRA.00579-19http://hdl.handle.net/2263/75608Staphylococcus aureus ATCC BAA-39 is the reference organism for a multidrug-resistant Staphylococcus aureus (MRSA) strain that was used to study druginduced resistance reversion by an iodine-containing nanomolecular complex, FS-1. PacBio sequencing was performed on both the experimental and control strains, followed by genome assembly, variant calling, and DNA modification profiling.en© 2019 Joubert et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.FS-1 DrugStaphylococcus aureusAntibiotic resistance reversalStrain analysisGenomeMultidrug-resistant Staphylococcus aureus (MRSA)Article